| Literature DB >> 32081888 |
Mohamed A Ellabban1, Islam Omar Abdel Fattah2, Ghada Abdel Kader2, Omar Salah Eldeen3, Amir E Mehana4, Dina M Khodeer5, Hossam Hosny6, Mahmoud S Elbasiouny7, Suhail Masadeh8.
Abstract
Smoking aggravates skin necrosis as a complication of random-pattern flap ischaemia. Sildenafil and nitroglycerin (NTG) are vasodilator agents that may affect skin flap survival. Fifty rats were subjected to a dorsal random-pattern flap operation and randomly divided into 5 groups. The control group received no treatment. The ischaemic group were administered local nicotine injections. The sildenafil group were administered oral sildenafil treatment in addition to the same intervention as the ischaemic group. The NTG group received topical NTG ointment application instead of sildenafil. The combined group were given both sildenafil and NTG treatments. After 7 days, all rats were sacrificed for flap assessment. Flap survival percentages at the 3rd and 7th days were significantly higher in the combined group than in the other study groups. Histologically, the ischaemic group exhibited dermal disorganization and inflammatory cell infiltration, which were improved in the 3 treated groups; however, the combined group presented the most relevant effect. The epidermal thickness showed a decrease in the ischaemic group (23.1 μm) that was significantly increased in the sildenafil (28.4 μm), NTG (28.8 μm) and combined (35.8 μm) groups. Immunohistochemically, the combined group exhibited a significant decrease in the apoptotic index and an increase in the proliferative index (2.3 and 56.9%, respectively) compared to those in the ischaemic (63.2 and 3%), sildenafil (41.7 and 28.1%) and NTG (39.3 and 30.4%) groups. Transmission electron microscopy (TEM) showed that the combined group displayed improvement in most of the ischaemic changes. Our analyses suggest that the combined use of sildenafil and NTG is more efficacious than using only one of these treatments for skin flap survival.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32081888 PMCID: PMC7035277 DOI: 10.1038/s41598-020-60128-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Percentages of skin flap survival at days 3 and 7 after operation of study groups.
Figure 2Gross appearance of skin flaps of the study groups at days 1, 3 and 7 after operation. (Scale bar = 2 cm).
Figure 3(A) Epidermal thickness. (B) Apoptotic and proliferative indices. aP < 0.05 vs control group, bP < 0.05 vs ischemic group, cP < 0.05 vs sildenafil group and dP < 0.05 vs NTG group. Statistical analysis was performed by ANOVA followed by Tukey’s post hoc test.